Mirabegron
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB08893 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | overactive bladder (disease) | DL |
| 2 | thoracic malformation | KG + DL |
| 3 | renal-hepatic-pancreatic dysplasia | KG + DL |
| 4 | polycystic kidney disease 3 with or without polycystic liver disease | KG + DL |
| 5 | Joubert syndrome with renal defect | KG + DL |
| 6 | adult familial nephronophthisis-spastic quadriparesia syndrome | KG + DL |
| 7 | esophageal varices without bleeding | KG + DL |
| 8 | esophageal varices with bleeding | KG + DL |
| 9 | hypotrichosis simplex of the scalp | KG + DL |
| 10 | karyomegalic interstitial nephritis | KG + DL |
| 11 | congenital hypotrichosis milia | KG + DL |
| 12 | 16q24.1 microdeletion syndrome | KG + DL |
| 13 | primary interstitial lung disease specific to childhood | KG + DL |
| 14 | isolated pulmonary capillaritis | KG + DL |
| 15 | low compliance bladder | KG + DL |
| 16 | diffuse alopecia areata | KG + DL |
| 17 | congenital pulmonary lymphangiectasia | KG + DL |
| 18 | polycystic kidney disease | KG + DL |
| 19 | varicose disease | KG + DL |
| 20 | autosomal ichthyosis syndrome with fatal disease course | KG + DL |
| 21 | congenital analbuminemia | KG + DL |
| 22 | sudden arrhythmia death syndrome | KG + DL |
| 23 | Polymerase proofreading-related adenomatous polyposis | KG + DL |
| 24 | polyclonal hyperviscosity syndrome | KG + DL |
| 25 | hyperamylasemia | KG + DL |
| 26 | hyperparathyroidism, primary, caused by water clear cell hyperplasia | KG + DL |
| 27 | ABetaL34V amyloidosis | KG + DL |
| 28 | cold-induced sweating syndrome | KG + DL |
| 29 | isolated sulfite oxidase deficiency | KG + DL |
| 30 | sclerocornea, autosomal dominant | KG + DL |
| 31 | uterine inversion | KG + DL |
| 32 | Taylor syndrome | KG + DL |
| 33 | adhesions of uterus | KG + DL |
| 34 | chronic subinvolution of uterus | KG + DL |
| 35 | female infertility of uterine origin | KG + DL |
| 36 | selective IgM deficiency | KG + DL |
| 37 | selective IgE deficiency disease | KG + DL |
| 38 | mixed receptive-expressive language disorder | KG + DL |
| 39 | aphasia | KG + DL |
| 40 | cardiac lipidosis, familial | KG + DL |
| 41 | Duane retraction syndrome 3 with or without deafness | KG + DL |
| 42 | inherited Fanconi renotubular syndrome | KG + DL |
| 43 | non-syndromic diaphragmatic or abdominal wall malformation | KG + DL |
| 44 | disorder of beta and omega amino acid metabolism | KG + DL |
| 45 | epilepsy, juvenile absence, susceptibility to, 1 | KG + DL |
| 46 | hemoglobin C-beta-thalassemia syndrome | KG + DL |
| 47 | multiple system atrophy, cerebellar type | KG + DL |
| 48 | basal ganglia calcification, idiopathic, 7, autosomal recessive | KG + DL |
| 49 | hernia, anterior diaphragmatic | KG + DL |
| 50 | benign infantile focal epilepsy with midline spikes and wave during sleep | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.